Cargando…
Understanding the Impact of Subsidizing Artemisinin-Based Combination Therapies (ACTs) in the Retail Sector – Results from Focus Group Discussions in Rural Kenya
BACKGROUND: There is considerable interest in the potential of private sector subsidies to increase availability and affordability of artemisinin-based combination therapies (ACTs) for malaria treatment. A cluster randomized trial of such subsidies was conducted in 3 districts in Kenya, comprising p...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544761/ https://www.ncbi.nlm.nih.gov/pubmed/23342143 http://dx.doi.org/10.1371/journal.pone.0054371 |
_version_ | 1782255845538529280 |
---|---|
author | Kedenge, Sarah V. Kangwana, Beth P. Waweru, Evelyn W. Nyandigisi, Andrew J. Pandit, Jayesh Brooker, Simon J. Snow, Robert W. Goodman, Catherine A. |
author_facet | Kedenge, Sarah V. Kangwana, Beth P. Waweru, Evelyn W. Nyandigisi, Andrew J. Pandit, Jayesh Brooker, Simon J. Snow, Robert W. Goodman, Catherine A. |
author_sort | Kedenge, Sarah V. |
collection | PubMed |
description | BACKGROUND: There is considerable interest in the potential of private sector subsidies to increase availability and affordability of artemisinin-based combination therapies (ACTs) for malaria treatment. A cluster randomized trial of such subsidies was conducted in 3 districts in Kenya, comprising provision of subsidized packs of paediatric ACT to retail outlets, training of retail staff, and community awareness activities. The results demonstrated a substantial increase in ACT availability and coverage, though patient counselling and adherence were suboptimal. We conducted a qualitative study in order to understand why these successes and limitations occurred. METHODOLOGY/PRINCIPAL FINDINGS: Eighteen focus group discussions were conducted, 9 with retailers and 9 with caregivers, to document experiences with the intervention. Respondents were positive about intervention components, praising the focused retailer training, affordable pricing, strong promotional activities, dispensing job aids, and consumer friendly packaging, which are likely to have contributed to the positive access and coverage outcomes observed. However, many retailers still did not stock ACT, due to insufficient supplies, lack of capital and staff turnover. Advice to caregivers was poor due to insufficient time, and poor recall of instructions. Adherence by caregivers to dosing guidelines was sub-optimal, because of a wish to save tablets for other episodes, doses being required at night, stopping treatment when the child felt better, and the number and bitter taste of the tablets. Caregivers used a number of strategies to obtain paediatric ACT for older age groups. CONCLUSIONS/SIGNIFICANCE: This study has highlighted that important components of a successful ACT subsidy intervention are regular retailer training, affordable pricing, a reliable supply chain and community mobilization emphasizing patient adherence and when to seek further care. |
format | Online Article Text |
id | pubmed-3544761 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-35447612013-01-22 Understanding the Impact of Subsidizing Artemisinin-Based Combination Therapies (ACTs) in the Retail Sector – Results from Focus Group Discussions in Rural Kenya Kedenge, Sarah V. Kangwana, Beth P. Waweru, Evelyn W. Nyandigisi, Andrew J. Pandit, Jayesh Brooker, Simon J. Snow, Robert W. Goodman, Catherine A. PLoS One Research Article BACKGROUND: There is considerable interest in the potential of private sector subsidies to increase availability and affordability of artemisinin-based combination therapies (ACTs) for malaria treatment. A cluster randomized trial of such subsidies was conducted in 3 districts in Kenya, comprising provision of subsidized packs of paediatric ACT to retail outlets, training of retail staff, and community awareness activities. The results demonstrated a substantial increase in ACT availability and coverage, though patient counselling and adherence were suboptimal. We conducted a qualitative study in order to understand why these successes and limitations occurred. METHODOLOGY/PRINCIPAL FINDINGS: Eighteen focus group discussions were conducted, 9 with retailers and 9 with caregivers, to document experiences with the intervention. Respondents were positive about intervention components, praising the focused retailer training, affordable pricing, strong promotional activities, dispensing job aids, and consumer friendly packaging, which are likely to have contributed to the positive access and coverage outcomes observed. However, many retailers still did not stock ACT, due to insufficient supplies, lack of capital and staff turnover. Advice to caregivers was poor due to insufficient time, and poor recall of instructions. Adherence by caregivers to dosing guidelines was sub-optimal, because of a wish to save tablets for other episodes, doses being required at night, stopping treatment when the child felt better, and the number and bitter taste of the tablets. Caregivers used a number of strategies to obtain paediatric ACT for older age groups. CONCLUSIONS/SIGNIFICANCE: This study has highlighted that important components of a successful ACT subsidy intervention are regular retailer training, affordable pricing, a reliable supply chain and community mobilization emphasizing patient adherence and when to seek further care. Public Library of Science 2013-01-14 /pmc/articles/PMC3544761/ /pubmed/23342143 http://dx.doi.org/10.1371/journal.pone.0054371 Text en © 2013 Kedenge et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Kedenge, Sarah V. Kangwana, Beth P. Waweru, Evelyn W. Nyandigisi, Andrew J. Pandit, Jayesh Brooker, Simon J. Snow, Robert W. Goodman, Catherine A. Understanding the Impact of Subsidizing Artemisinin-Based Combination Therapies (ACTs) in the Retail Sector – Results from Focus Group Discussions in Rural Kenya |
title | Understanding the Impact of Subsidizing Artemisinin-Based Combination Therapies (ACTs) in the Retail Sector – Results from Focus Group Discussions in Rural Kenya |
title_full | Understanding the Impact of Subsidizing Artemisinin-Based Combination Therapies (ACTs) in the Retail Sector – Results from Focus Group Discussions in Rural Kenya |
title_fullStr | Understanding the Impact of Subsidizing Artemisinin-Based Combination Therapies (ACTs) in the Retail Sector – Results from Focus Group Discussions in Rural Kenya |
title_full_unstemmed | Understanding the Impact of Subsidizing Artemisinin-Based Combination Therapies (ACTs) in the Retail Sector – Results from Focus Group Discussions in Rural Kenya |
title_short | Understanding the Impact of Subsidizing Artemisinin-Based Combination Therapies (ACTs) in the Retail Sector – Results from Focus Group Discussions in Rural Kenya |
title_sort | understanding the impact of subsidizing artemisinin-based combination therapies (acts) in the retail sector – results from focus group discussions in rural kenya |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544761/ https://www.ncbi.nlm.nih.gov/pubmed/23342143 http://dx.doi.org/10.1371/journal.pone.0054371 |
work_keys_str_mv | AT kedengesarahv understandingtheimpactofsubsidizingartemisininbasedcombinationtherapiesactsintheretailsectorresultsfromfocusgroupdiscussionsinruralkenya AT kangwanabethp understandingtheimpactofsubsidizingartemisininbasedcombinationtherapiesactsintheretailsectorresultsfromfocusgroupdiscussionsinruralkenya AT waweruevelynw understandingtheimpactofsubsidizingartemisininbasedcombinationtherapiesactsintheretailsectorresultsfromfocusgroupdiscussionsinruralkenya AT nyandigisiandrewj understandingtheimpactofsubsidizingartemisininbasedcombinationtherapiesactsintheretailsectorresultsfromfocusgroupdiscussionsinruralkenya AT panditjayesh understandingtheimpactofsubsidizingartemisininbasedcombinationtherapiesactsintheretailsectorresultsfromfocusgroupdiscussionsinruralkenya AT brookersimonj understandingtheimpactofsubsidizingartemisininbasedcombinationtherapiesactsintheretailsectorresultsfromfocusgroupdiscussionsinruralkenya AT snowrobertw understandingtheimpactofsubsidizingartemisininbasedcombinationtherapiesactsintheretailsectorresultsfromfocusgroupdiscussionsinruralkenya AT goodmancatherinea understandingtheimpactofsubsidizingartemisininbasedcombinationtherapiesactsintheretailsectorresultsfromfocusgroupdiscussionsinruralkenya |